Clinical Trials
Keyword Search All Trials- Treatment of apathy in Alzheimer's disease (AD) with modafinil
- Alzheimer's Disease Neuroimaging Initiative (ADNI)
- Coping Long Term with Suicide Program
- Mood Management Phone Counseling in Smoking Cessation
- Development of a Treatment Adherence Program for Bipolar Substance Abusers
- Behavioral Exercise Intervention for Smoking Cessation
- Motivational Interviewing for Teen Substance Use with Comorbid Psychiatric Disorder
- Fluoxetine Smoking Cessation Study
- Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder
- Fluoxetine in Pediatric Body Dysmorphic Disorder
- Development of a Psychosocial Treatment for Psychotic Depression
- A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety trial of bapineuzumab in patients with mild to moderate Alzheimer's disease.
- Phase IIa, multicenter, randomized, third-party unblinded, adjuvant and placebo-controlled, multiple ascending dose, safety, tolerability and immunogenicity trial of ACC-001 and QS-21 adjuvant in subjects with mild to moderate Alzheimer’s Disease